Drug Trial Radar · NCT02249104
A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris
Last checked: Nov 20, 2026Latest source record: Aug 23, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
28
Actual
Start
Aug 2014
Primary completion
Feb 2015
Study completion Feb 2015
Sponsor
- Lead sponsor
- Galderma R&DIndustry
- Sponsor type
- Industry
- First posted
- Sep 25, 2014
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this study is to evaluate a complete topical acne regimen consisting of a prescription acne medication (Epiduo® Gel) and an acne-specific cleanser (Cetaphil® DermaControl™ Foam Wash) and moisturizer with sunscreen (Cetaphil® DermaControl™ Moisturizer SPF 30) for safety, efficacy and patient satisfaction in student athletes with acne vulgaris.
Conditions
- Acne Vulgaris
Interventions
Adapalene/benzoyl peroxide gel, 0.1%/2.5%Drug
Topical AV therapy
Cetaphil Acne RegimenOther
Cleanse, Moisturize, and Protect
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Change From Baseline in Total Lesion CountTime frame: Baseline and 8 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Pflugerville Dermatology Clinical Research
Pflugerville, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.